Metformin Cost in Louisiana 2026: Cash Price, Medicaid, and Discount Options

At a glance
- Cash price (retail, Louisiana) / ~$8/month for generic tablets
- Manufacturer list price / ~$40/month for various generics
- Louisiana Medicaid / covers metformin for eligible members
- Compounded metformin (503A pharmacies) / legally available in Louisiana
- Telehealth prescribing / permitted in Louisiana
- Typical dose / 500, 2 to 000 mg/day taken twice daily with food
- Savings programs / GoodRx, manufacturer coupons, 340B clinics
- FDA approval status / approved 1994 for type 2 diabetes management
What Does Metformin Actually Cost in Louisiana in 2026?
Generic metformin is one of the least expensive prescription drugs available in Louisiana. At most retail chains, a 30-day supply runs about $8 when paid without insurance. Manufacturer list prices sit closer to $40 per month, but almost no cash-paying patient actually pays that amount.
Metformin hydrochloride is the active ingredient in brand-name Glucophage, first approved by the FDA in 1994 for type 2 diabetes mellitus [1]. Because the patent expired decades ago, a competitive generic market now exists. The American Diabetes Association (ADA) 2024 Standards of Care describes metformin as "the preferred initial pharmacological agent for the management of type 2 diabetes" given its efficacy, safety, and low cost [2]. That cost advantage is very real for Louisiana patients.
Price can vary by pharmacy. Walmart charges $4 for a 30-day supply of metformin 500 mg under its $4 generic program. Kroger, Walgreens, and CVS generally charge $8 to $12 for the same supply without any discount card. Extended-release formulations (metformin ER) may run $10 to $20 per month at retail because fewer manufacturers compete on that specific form.
The UKPDS 34 trial (N=753 overweight patients with type 2 diabetes, Lancet 1998) demonstrated that metformin reduced all-cause mortality by 36% and myocardial infarction by 39% compared with conventional dietary management over a median 10.7-year follow-up [3]. Given that established cardiovascular benefit, paying the lowest possible price for an effective drug is a genuine public-health concern for Louisiana's population, where adult diabetes prevalence exceeds the national average [4].
The Diabetes Prevention Program (DPP) trial (N=3,234, NEJM 2002) showed metformin 850 mg twice daily reduced progression from prediabetes to type 2 diabetes by 31% compared with placebo over 2.8 years [5]. Louisiana physicians can prescribe metformin off-label for prediabetes, though coverage for that indication varies by payer.
Does Louisiana Medicaid Cover Metformin?
Louisiana Medicaid covers metformin for eligible members, and it appears on the Louisiana Medicaid Preferred Drug List (PDL) as a preferred agent for type 2 diabetes [6]. Members with qualifying diagnoses typically pay a nominal copay of $1 to $3 per fill, depending on their specific plan tier.
Medicaid expansion under the ACA brought coverage to roughly 700,000 additional Louisiana residents. Enrollment in Medicaid means most members owe near-zero out-of-pocket for first-line generic medications like metformin. Louisiana Medicaid uses managed care organizations (MCOs), and each MCO follows the state PDL; metformin generic tablets appear on every MCO formulary reviewed for 2026.
For prediabetes, Medicaid coverage is less consistent. The program generally covers metformin only when the prescriber documents a diagnosis of type 2 diabetes (ICD-10 E11.x) or polycystic ovary syndrome (PCOS, E28.2) on the claim. Prediabetes (R73.03) may require a prior authorization. Patients in that situation should ask their provider to document both diagnoses on the prescription if both apply.
Louisiana Medicaid also covers some Diabetes Prevention Program (DPP) lifestyle interventions, which the CDC recognizes as a complement to metformin therapy [7]. Combining a structured DPP with metformin is a reasonable approach for high-risk prediabetes patients, particularly those with a body mass index at or above 35 kg/m².
Which Insurance Plans Cover Metformin in Louisiana?
Most commercial insurance plans in Louisiana place generic metformin on Tier 1 of the formulary, meaning the lowest possible copay, typically $0 to $10 per 30-day supply [8]. Tier 1 status reflects metformin's position as a preferred, first-line agent in every major diabetes guideline.
Louisiana's largest commercial insurers, including Blue Cross Blue Shield of Louisiana, Humana, UnitedHealthcare, and Aetna, all list generic metformin as a Tier 1 covered drug for type 2 diabetes. Employer-sponsored high-deductible health plans (HDHPs) may require a patient to meet their deductible first, but the actual drug cost after deductible is usually under $10.
Medicare Part D also covers metformin. CMS data for 2024 show metformin hydrochloride tablets 500 mg rank among the top 20 most dispensed drugs under Part D nationally, with average patient cost under $5 per fill for low-income subsidy (LIS) beneficiaries [9]. Louisiana has a higher-than-average proportion of Medicare recipients with LIS eligibility due to the state's poverty rate.
One coverage gap worth noting: brand-name Glucophage XR is not always covered, and some plans restrict metformin ER to Step Therapy, requiring a trial of immediate-release metformin first. If a patient has documented gastrointestinal intolerance to immediate-release formulations, the prescriber can usually submit a medical necessity exception.
What Are the Cheapest Ways to Get Metformin in Louisiana?
The cheapest single option is the Walmart $4 generic program, available at all Louisiana Walmart pharmacy locations. No membership or discount card is needed; the patient simply asks for the $4 price at the counter [10].
GoodRx coupons routinely bring metformin to $4 to $9 at most Louisiana chain pharmacies. The GoodRx price at a Walgreens or CVS in Baton Rouge or New Orleans currently sits around $8 for a 60-tablet supply of metformin 500 mg, which is a 30-day supply at twice-daily dosing. GoodRx is free to use and does not require insurance.
Mark Cuban's Cost Plus Drugs (costplusdrugs.com) lists metformin 500 mg at approximately $4 for 60 tablets plus a $5 shipping fee. For patients filling 90-day supplies, the per-dose cost drops further. Cost Plus Drugs ships to Louisiana addresses and requires a valid prescription.
340B-eligible community health centers, Federally Qualified Health Centers (FQHCs), and certain rural health clinics in Louisiana can dispense metformin at or near cost under the 340B Drug Pricing Program, sometimes at no charge to uninsured low-income patients [11]. Louisiana has over 60 FQHC sites, including those operated by CrescentCare, Access Health Louisiana, and the LSU Health primary care network.
Bringing a 90-day supply prescription instead of a 30-day prescription often reduces the per-month cost by 10 to 20% at retail pharmacies simply due to dispensing-fee structure.
Is Compounded Metformin Legal in Louisiana?
Compounded metformin is legally available in Louisiana through state-licensed 503A compounding pharmacies [12]. A 503A pharmacy compounds for an individual patient based on a valid, patient-specific prescription from a licensed prescriber.
The Louisiana Board of Pharmacy licenses and inspects 503A facilities. Compounded metformin preparations may include custom dose forms (such as liquid suspensions for patients who cannot swallow tablets or modified-dose capsules) and are typically prepared without certain commercial excipients that can cause gastrointestinal side effects in some patients.
Cost is the other reason patients ask about compounded metformin. In some cases, a compounded preparation may be provided at low or no cost within an integrated telehealth or direct-primary-care membership program. Outside such programs, a compounded preparation from a standalone 503A pharmacy may actually cost more than the $4 to $8 retail generic because it requires custom preparation labor.
The FDA does not approve compounded drug preparations; it approves only finished pharmaceutical products from licensed manufacturers [13]. Patients should confirm that any compounding pharmacy they use holds a current Louisiana Board of Pharmacy 503A registration. The FDA's guidance on 503A pharmacies (21 U.S.C. 353a) specifies that compounded preparations cannot be commercially equivalent copies of commercially available products unless there is a documented clinical difference for the specific patient [14]. A prescriber who documents a medical reason (such as GI intolerance to commercial excipients) can legally request a compounded metformin preparation for that patient.
Can You Get Metformin via Telehealth in Louisiana?
Telehealth prescribing of metformin is permitted in Louisiana [15]. A licensed Louisiana physician, nurse practitioner, or physician assistant can evaluate a patient via synchronous audio-video telehealth and issue a valid prescription for metformin if clinically appropriate.
Louisiana follows the Federation of State Medical Boards (FSMB) telehealth guidelines, which require a valid prescriber-patient relationship established through a real-time clinical evaluation [16]. Asynchronous (store-and-forward) prescribing of controlled substances is restricted, but metformin is not a controlled substance, so that restriction does not apply.
Telehealth platforms serving Louisiana patients, including HealthRX, can initiate a metformin prescription after reviewing relevant labs (fasting glucose, HbA1c, basic metabolic panel for renal function), medical history, and current medications. The FDA label requires an estimated glomerular filtration rate (eGFR) check before starting metformin and periodically during therapy; metformin is contraindicated when eGFR falls below 30 mL/min/1.73 m² and requires caution when eGFR is 30 to 45 mL/min/1.73 m² [1].
A telehealth clinician should use the following decision framework before prescribing metformin to a Louisiana patient:
- Confirm diagnosis (type 2 diabetes, prediabetes, or PCOS) with supporting labs.
- Check eGFR. Withhold if eGFR < 30; prescribe with monitoring and dose reduction guidance if eGFR is 30 to 45.
- Review for contraindications: active hepatic disease, active alcohol misuse, scheduled iodinated contrast procedures.
- Start at 500 mg once daily with the evening meal to minimize GI side effects, titrating by 500 mg per week to a target of 1,500 to 2 to 000 mg/day in divided doses [2].
- Order or review HbA1c at baseline and at 3 months post-initiation.
- Document the clinical encounter fully to satisfy Louisiana telehealth prescribing standards.
Patients can send their prescription electronically to any Louisiana pharmacy or to a mail-order pharmacy. Most Louisiana telehealth visits for an established medication like metformin cost $39 to $75 without insurance, which is offset quickly by the drug's low cost.
How Effective Is Metformin? Key Trial Data
Effectiveness data justify the drug's first-line status. UKPDS 34 (Lancet 1998, N=753) showed metformin-allocated overweight patients had a 32% reduction in any diabetes-related endpoint versus conventional therapy (P<0.002) [3]. HbA1c reductions in clinical practice typically range from 1.0 to 2.0 percentage points from baseline, depending on starting HbA1c.
The DPP trial (NEJM 2002, N=3,234) showed metformin 850 mg twice daily cut diabetes incidence by 31% relative to placebo, with the greatest effect in adults aged 25 to 44 and in those with higher baseline fasting glucose [5]. A 10-year DPP Outcomes Study follow-up published in Lancet (2009) showed the diabetes prevention benefit persisted even after the structured intervention ended, with a 18% lower diabetes incidence in the metformin group versus placebo [17].
The ADA 2024 Standards of Care states: "Metformin is safe, effective, inexpensive, and may reduce the risk of cardiovascular events and death" [2]. That language, direct and unambiguous, reflects 30 years of post-marketing safety data across hundreds of millions of patient-years.
For weight, metformin produces modest reductions averaging 2 to 3 kg over 12 to 24 weeks in most studies, far below GLP-1 receptor agonists but meaningful for patients who cannot access or afford those agents [18]. A 2022 Cochrane review of metformin for type 2 diabetes (including 300+ trials) confirmed no increase in lactic acidosis risk versus other oral agents at normal renal function, contradicting a historical concern that persisted for decades [19].
Metformin for Weight Loss and Longevity: What Louisiana Prescribers Are Seeing
Off-label prescribing of metformin for weight management and aging-related outcomes has increased nationally. The TAME (Targeting Aging with Metformin) trial, a 6-year NIH-funded multicenter study (N=3,000 adults aged 65 to 79 without diabetes), is currently ongoing and will report on whether metformin delays age-related disease clusters [20]. Results are expected in the late 2020s.
Louisiana clinicians prescribing metformin off-label for weight loss or longevity should document the clinical rationale in the chart. Insurance plans, including Louisiana Medicaid, generally will not cover metformin dispensed solely for weight management or anti-aging without a covered diagnosis code. The cash-pay price of $4 to $8 per month makes this financially accessible even without coverage.
B12 deficiency is the most clinically significant long-term adverse effect of metformin use. A large observational analysis (N=155,771 patients) found metformin use for more than 3 years was associated with a 22% higher odds of B12 deficiency [21]. The ADA recommends periodic measurement of serum B12 in long-term metformin users, particularly those on doses at or above 2 to 000 mg/day [2].
Louisiana-Specific Resources for Metformin Access
Several resources are specific to Louisiana patients seeking low-cost metformin access:
The Louisiana Department of Health administers the Louisiana Medicaid Preferred Drug List, which lists metformin as a preferred Tier 1 agent [6]. Patients can check eligibility at ldh.la.gov.
The Louisiana Primary Care Association (LPCA) coordinates the state's FQHC network. FQHCs in New Orleans, Baton Rouge, Shreveport, Lafayette, and Lake Charles can provide metformin at low or no cost to uninsured patients through the 340B program [11].
LSU Health Sciences Center clinics and Tulane Medical Center outpatient diabetes programs offer sliding-scale fees and formulary access for uninsured and underinsured patients in Southeast Louisiana.
The Louisiana Diabetes Coalition (part of the Louisiana Public Health Institute) tracks diabetes prevention program sites, many of which include medication support services for participants [4]. Enrolled DPP participants may receive referrals to low-cost pharmacy programs as part of their structured lifestyle intervention.
Frequently asked questions
›How much does metformin cost in Louisiana?
›Does Louisiana Medicaid cover metformin?
›Is compounded metformin legal in Louisiana?
›Can I get metformin via telehealth in Louisiana?
›Which insurance plans cover metformin in Louisiana?
›What's the cheapest way to get metformin in Louisiana?
›Are there Louisiana metformin discount programs?
›How does the GoodRx savings card work in Louisiana?
›Does Louisiana cover metformin for prediabetes?
›What labs are needed before starting metformin in Louisiana?
References
- US Food and Drug Administration. Metformin hydrochloride tablets prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020357s037s039,021202s021s023lbl.pdf
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes 2024. Diabetes Care. 2024;47(Suppl 1):S1-S321. https://diabetesjournals.org/care/issue/47/Supplement_1
- UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854-865. https://pubmed.ncbi.nlm.nih.gov/9742976/
- Centers for Disease Control and Prevention. Diabetes Data and Statistics: State Profiles. CDC.gov. https://www.cdc.gov/diabetes/data/statistics-report/index.html
- Knowler WC, Barrett-Connor E, Fowler SE, et al; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403. https://pubmed.ncbi.nlm.nih.gov/11832527/
- Louisiana Department of Health. Louisiana Medicaid Preferred Drug List. LDH.la.gov. https://www.ldh.la.gov/page/pharmacy-benefits-management
- Centers for Disease Control and Prevention. National Diabetes Prevention Program. CDC.gov. https://www.cdc.gov/diabetes/prevention/index.html
- Fralick M, Kesselheim AS. The US insulin crisis, rationing a lifesaving medication discovered in the 1920s. N Engl J Med. 2019;381(19):1793-1795. https://pubmed.ncbi.nlm.nih.gov/31693804/
- Centers for Medicare and Medicaid Services. Medicare Part D Drug Spending Dashboard and Data. CMS.gov. https://www.cms.gov/data-research/statistics-trends-and-reports/medicare-provider-utilization-payment-data/part-d-prescriber
- US Food and Drug Administration. Generic Drug Facts. FDA.gov. https://www.fda.gov/drugs/generic-drugs/generic-drug-facts
- Health Resources and Services Administration. 340B Drug Pricing Program. HRSA.gov. https://www.hrsa.gov/opa/index.html
- US Food and Drug Administration. Compounding: 503A Pharmacy Compounding. FDA.gov. https://www.fda.gov/drugs/human-drug-compounding/503a-pharmacies
- US Food and Drug Administration. Human Drug Compounding. FDA.gov. https://www.fda.gov/drugs/guidance-regulation-drug-manufacturers-distributors-and-retailers/human-drug-compounding
- US Food and Drug Administration. Guidance: Compounding Under the Federal Food, Drug, and Cosmetic Act. FDA.gov. https://www.fda.gov/media/89936/download
- Federation of State Medical Boards. Telemedicine and the Practice of Medicine. FSMB.org. https://www.fsmb.org/advocacy/policies/telemedicine/
- Federation of State Medical Boards. Model Policy for the Appropriate Use of Telemedicine in Medical Practice. 2020. https://www.fsmb.org/siteassets/advocacy/policies/telemedicine-coverage-policy.pdf
- Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677-1686. https://pubmed.ncbi.nlm.nih.gov/19878986/
- Seifarth C, Schehler B, Schneider HJ. Effectiveness of metformin on weight loss in non-diabetic individuals with obesity. Exp Clin Endocrinol Diabetes. 2013;121(1):27-31. https://pubmed.ncbi.nlm.nih.gov/23152069/
- Hemmingsen B, Schroll JB, Lund SS, et al. Metformin monotherapy for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2019;(6):CD002966. https://pubmed.ncbi.nlm.nih.gov/31185122/
- Barzilai N, Crandall JP, Kritchevsky SB, Espeland MA. Metformin as a tool to target aging. Cell Metab. 2016;23(6):1060-1065. https://pubmed.ncbi.nlm.nih.gov/27304507/
- Aroda VR, Edelstein SL, Goldberg RB, et al. Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab. 2016;101(4):1754-1761. https://pubmed.ncbi.nlm.nih.gov/26900641/